ETC
CORT icon

Exchange Traded Concepts’s Corcept Therapeutics CORT Stock Holding History

Exchange Traded Concepts’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,704
Closed -$59.3K – 1552
2025
Q4 		$59.3K Buy
1,704
+60
+4% +$4.71K ﹤0.01% 1445
2025
Q3 		$137K Buy
+1,644
New +$119K ﹤0.01% 1233
2025
Q2 		– Sell
-8,985
Closed -$1.03M – 1426
2025
Q1 		$1.03M Sell
8,985
-349
-4% -$21.2K 0.02% 553
2024
Q4 		$470K Sell
9,334
-5,499
-37% -$288K 0.01% 798
2024
Q3 		$686K Sell
14,833
-62,213
-81% -$2.21M 0.02% 700
2024
Q2 		$2.5M Buy
77,046
+13,561
+21% +$371K 0.06% 254
2024
Q1 		$1.6M Buy
63,485
+19,037
+43% +$450K 0.04% 327
2023
Q4 		$1.44M Buy
44,448
+641
+1% +$17.6K 0.04% 326
2023
Q3 		$1.19M Buy
43,807
+42,645
+3,670% +$1.23M 0.03% 343
2023
Q2 		$25.9K Sell
1,162
-23
-2% -$529 ﹤0.01% 1144
2023
Q1 		$25.7K Sell
1,185
-28
-2% -$614 ﹤0.01% 948
2022
Q4 		$24.6K Sell
1,213
-72
-6% -$1.8K ﹤0.01% 949
2022
Q3 		$33K Buy
1,285
+161
+14% +$4.31K ﹤0.01% 910
2022
Q2 		$27K Buy
1,124
+84
+8% +$1.83K ﹤0.01% 976
2022
Q1 		$23K Sell
1,040
-27,325
-96% -$581K ﹤0.01% 1017
2021
Q4 		$562K Buy
28,365
+927
+3% +$18.8K 0.01% 612
2021
Q3 		$540K Sell
27,438
-9,841
-26% -$206K 0.01% 530
2021
Q2 		$820K Buy
37,279
+4,089
+12% +$91K 0.03% 364
2021
Q1 		$790K Sell
33,190
-6,401
-16% -$171K 0.03% 330
2020
Q4 		$1.04M Buy
39,591
+3,876
+11% +$81.7K 0.05% 219
2020
Q3 		$622K Sell
35,715
-1,886
-5% -$30.1K 0.04% 250
2020
Q2 		$632K Buy
+37,601
New +$528K 0.1% 161

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Exchange Traded Concepts's CORT Position: Q1 2026 in Review

Exchange Traded Concepts sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 1,704 shares — an estimated $59.3K sold.

Exchange Traded Concepts first reported a position in CORT in Q2 2020 and held it in 22 quarters. The position peaked at $2.5M in Q2 2024. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Exchange Traded Concepts reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 1,704 Corcept Therapeutics shares in Q1 2026, an estimated $59.3K.
  • Exchange Traded Concepts first reported a position in Corcept Therapeutics in Q2 2020 and held it in 22 quarters.
  • Exchange Traded Concepts's Corcept Therapeutics position peaked at $2.5M in Q2 2024.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.